Kenya

The proposed 50-bed unit at the Laikipia Air Base quarantine facility, scheduled to become operational on May 29

Phesgo, manufactured by Roche, contains a combination of Pertuzumab and Trastuzumab and is used in the treatment of specific types of breast cancer.

The hospital conducted the procedures in collaboration with Pentaprism Medical Africa through a skills transfer and clinical training programme designed to strengthen minimally invasive surgical care at the facility.

Kenya aligned its position with the African regional statement presented by Zimbabwe on behalf of the WHO African Region, reinforcing a continent-wide call for equity at the heart of global health governance and emergency response.

WHO validated the elimination in June 2025, and Kenya made a national announcement in August 2025 before formally receiving the certification in Geneva.

Under the partnership, IVI will collaborate closely with institutions such as the Kenya Medical Research Institute, the Kenya BioVax Institute, and the Pharmacy and Poisons Board to support vaccine development, manufacturing, and regulatory strengthening.

The next phase will focus on installing and validating fill-and-finish equipment, strengthening quality control systems, building specialized workforce capacity, and preparing for compliant vaccine manufacturing.

Through the proposed partnership, Africa CDC and Aspen plan to establish a multi-year collaboration to boost local manufacturing capacity, improve supply security, and create sustainable markets for African-made vaccines.

The financing consortium includes Proparco, the European Investment Bank through the Human Development Accelerator initiative, and the International Finance Corporation.